Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > Press > Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)

Abstract:
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that as an inducement to entering into employment with the Company, on September 11, 2020, the Compensation Committee of the Board of Directors approved “inducement” grants to 30 new employees under Rule 5635(c)(4) of the NASDAQ Marketplace Rules.

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)

Pasadena. CA | Posted on September 29th, 2020

The option grants entitle employees, in aggregate, to purchase up to 173,000 shares of common stock and receive up to 140,450 restricted stock units. The strike price of the options is set at an exercise price of $33.80, the last reported closing price of the Company’s common stock on September 11, 2020, the date of grant, except for certain shares which will be priced at the last reported closing price of the Company’s common stock on the date of hire of 10 new employees anticipated to be within two months of the date of the approval. The grants are outside the Company’s stockholder-approved equity incentive plans. The options vest and become exercisable over a period of four years. The RSUs vest annually over either one or four years.

####

About Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing.

For more information, please visit www.arrowheadpharma.com, or follow us on Twitter @ArrowheadPharma. To be added to the Company's email list and receive news directly, please visit http://ir.arrowheadpharma.com/email-alerts.

Safe Harbor Statement under the Private Securities Litigation Reform Act:

This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the safety and efficacy of our product candidates, the duration and impact of regulatory delays in our clinical programs, our ability to finance our operations, the future success of our scientific studies, our ability to successfully develop drug candidates, the timing for starting and completing clinical trials, rapid technological change in our markets, and the enforcement of our intellectual property rights. Our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q discuss some of the important risk factors that may affect our business, results of operations and financial condition. We assume no obligation to update or revise forward-looking statements to reflect new events or circumstances.

For more information, please click here

Contacts:
Arrowhead Pharmaceuticals, Inc.
Vince Anzalone, CFA
626-304-3400


Investors:
LifeSci Advisors, LLC
Brian Ritchie
212-915-2578

www.lifesciadvisors.com

Media:
LifeSci Communications, LLC
Josephine Belluardo, Ph.D.
646-751-4361

www.lifescicommunications.com

Copyright © Arrowhead Pharmaceuticals, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Timekeeping theory combines quantum clocks and Einstein's relativity: Research reveals new time dilation phenomenon October 23rd, 2020

New test method to standardize immunological evaluation of nucleic acid nanoparticles: Researchers believe accurate, affordable and easily reproduced protocol for assessing immune effects could further research collaboration and advance therapeutic use of new medicines October 23rd, 2020

Cicada-inspired waterproof surfaces closer to reality, researchers report October 23rd, 2020

Trailblazing theoretical physicist Sylvester James Gates Jr. is among speakers at nanotechnology symposium: Annual event moves to virtual format, open to attendees worldwide at no charge Oct. 29 October 23rd, 2020

Govt.-Legislation/Regulation/Funding/Policy

Cicada-inspired waterproof surfaces closer to reality, researchers report October 23rd, 2020

NSF renews Rice-based NEWT Center for water treatment: Partnership primed to introduce game-changing technologies to address global needs October 15th, 2020

New NIST project to build nano-thermometers could revolutionize temperature imaging: Cheaper refrigerators? Stronger hip implants? A better understanding of human disease? All of these could be possible October 9th, 2020

Graphene detector reveals THz light's polarization October 8th, 2020

Investments/IPO's/Splits

180 Degree Capital Corp. Invests Additional Capital in TheMaven, Inc. and Provides QTD Public Portfolio Update (+22.1% / +$0.32 Per Share) September 10th, 2020

Nanogate: Meeting of creditors on November 4, 2020 September 4th, 2020

180 Degree Capital Corp. to Report Second Quarter 2020 Financial Results on Monday, August 10, 2020 and to Host a Conference Call on Tuesday, August 11, 2020 August 7th, 2020

Izon Science receives $10.5M investment from Bolton Equities: Christchurch-headquartered nanotech company secures investment to accelerate global growth; appoints top board chairman and directors July 28th, 2020

Nanomedicine

New test method to standardize immunological evaluation of nucleic acid nanoparticles: Researchers believe accurate, affordable and easily reproduced protocol for assessing immune effects could further research collaboration and advance therapeutic use of new medicines October 23rd, 2020

Octopus-inspired sucker transfers thin, delicate tissue grafts and biosensors October 16th, 2020

Controlling the speed of enzyme motors brings biomedical applications of nanorobots closer: Recent advances in this field have made micro- and nanomotors promising devices for solving many biomedical problems October 13th, 2020

New drug carrier systems: University of Delaware researchers advance drug delivery systems to treat connective tissue disorders October 9th, 2020

Announcements

Timekeeping theory combines quantum clocks and Einstein's relativity: Research reveals new time dilation phenomenon October 23rd, 2020

New test method to standardize immunological evaluation of nucleic acid nanoparticles: Researchers believe accurate, affordable and easily reproduced protocol for assessing immune effects could further research collaboration and advance therapeutic use of new medicines October 23rd, 2020

Cicada-inspired waterproof surfaces closer to reality, researchers report October 23rd, 2020

Trailblazing theoretical physicist Sylvester James Gates Jr. is among speakers at nanotechnology symposium: Annual event moves to virtual format, open to attendees worldwide at no charge Oct. 29 October 23rd, 2020

Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records

Graphenea awarded “Best Graphene Firm” prize October 20th, 2020

Revealing the reason behind jet formation at the tip of laser optical fiber October 16th, 2020

NSF renews Rice-based NEWT Center for water treatment: Partnership primed to introduce game-changing technologies to address global needs October 15th, 2020

Shape matters for light-activated nanocatalysts - Study: Pointed tips on aluminum 'octopods' increase catalytic reactivity September 18th, 2020

Nanobiotechnology

New test method to standardize immunological evaluation of nucleic acid nanoparticles: Researchers believe accurate, affordable and easily reproduced protocol for assessing immune effects could further research collaboration and advance therapeutic use of new medicines October 23rd, 2020

Octopus-inspired sucker transfers thin, delicate tissue grafts and biosensors October 16th, 2020

Controlling the speed of enzyme motors brings biomedical applications of nanorobots closer: Recent advances in this field have made micro- and nanomotors promising devices for solving many biomedical problems October 13th, 2020

New drug carrier systems: University of Delaware researchers advance drug delivery systems to treat connective tissue disorders October 9th, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project